Foghorn Therapeutics Inc. financial statements, including revenue, expenses, profit, and loss
The total revenue of FHTX for the last quarter is 7.81 M USD, and it's 13.36% higher compared to the previous quarter. The net income of Q3 24 is -19.12 M USD.